Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1 DJ Klionsky, AK Abdel-Aziz, S Abdelfatah, M Abdellatif, A Abdoli, S Abel, ... autophagy 17 (1), 1-382, 2021 | 10965 | 2021 |
Nano-strategies to fight multidrug resistant bacteria—“A Battle of the Titans” PV Baptista, MP McCusker, A Carvalho, DA Ferreira, NM Mohan, ... Frontiers in microbiology 9, 1441, 2018 | 876 | 2018 |
Tauroursodeoxycholic acid prevents MPTP-induced dopaminergic cell death in a mouse model of Parkinson’s disease M Castro-Caldas, AN Carvalho, E Rodrigues, CJ Henderson, CR Wolf, ... Molecular neurobiology 46, 475-486, 2012 | 165 | 2012 |
Oxidative stress and antioxidants in neurological diseases: is there still hope? A Neves Carvalho, O Firuzi, M Joao Gama, J van Horssen, L Saso Current drug targets 18 (6), 705-718, 2017 | 156 | 2017 |
Glutathione in multiple sclerosis: More than just an antioxidant? AN Carvalho, JL Lim, N Philip G, ME Witte, V Horssen J Multiple Sclerosis Journal, 2014 | 121 | 2014 |
Nrf2 activation by tauroursodeoxycholic acid in experimental models of Parkinson's disease S Moreira, I Fonseca, MJ Nunes, A Rosa, L Lemos, E Rodrigues, ... Experimental Neurology 295, 77-87, 2017 | 100 | 2017 |
S‐Glutathionylation of Keap1: a new role for glutathione S‐transferase pi in neuronal protection AN Carvalho, C Marques, RC Guedes, M Castro‐Caldas, E Rodrigues, ... FEBS letters 590 (10), 1455-1466, 2016 | 87 | 2016 |
Tauroursodeoxycholic acid improves motor symptoms in a mouse model of Parkinson’s disease AI Rosa, S Duarte-Silva, A Silva-Fernandes, MJ Nunes, AN Carvalho, ... Molecular neurobiology 55, 9139-9155, 2018 | 85 | 2018 |
Novel insights into the antioxidant role of tauroursodeoxycholic acid in experimental models of Parkinson's disease AI Rosa, I Fonseca, MJ Nunes, S Moreira, E Rodrigues, AN Carvalho, ... Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1863 (9 …, 2017 | 83 | 2017 |
RuII(p-cymene) Compounds as Effective and Selective Anticancer Candidates with No Toxicity in Vivo OA Lenis-Rojas, MP Robalo, AI Tomaz, A Carvalho, AR Fernandes, ... Inorganic chemistry 57 (21), 13150-13166, 2018 | 74 | 2018 |
Glutathione S-Transferase pi Mediates MPTP-Induced c-Jun N-Terminal Kinase Activation in the Nigrostriatal Pathway M Castro-Caldas, AN Carvalho, E Rodrigues, C Henderson, CR Wolf, ... Molecular Neurobiology 45, 466-477, 2012 | 62 | 2012 |
Nanoparticles as delivery systems in cancer therapy: focus on gold nanoparticles and drugs A Carvalho, AR Fernandes, PV Baptista Applications of targeted nano drugs and delivery systems, 257-295, 2019 | 55 | 2019 |
GSTpi expression in MPTP-induced dopaminergic neurodegeneration of C57BL/6 mouse midbrain and striatum M Castro-Caldas, A Neves Carvalho, I Peixeiro, E Rodrigues, ... Journal of molecular neuroscience 38 (2), 114-127, 2009 | 47 | 2009 |
Neurotoxic effects of MPTP on mouse cerebral cortex: Modulation of neuroinflammation as a neuroprotective strategy MO Mendes, AI Rosa, AN Carvalho, MJ Nunes, P Dionísio, E Rodrigues, ... Molecular and Cellular Neuroscience 96, 1-9, 2019 | 30 | 2019 |
Ubiquitin–proteasome system impairment and MPTP-induced oxidative stress in the brain of C57BL/6 wild-type and GSTP knockout mice AN Carvalho, C Marques, E Rodrigues, CJ Henderson, CR Wolf, ... Molecular neurobiology 47, 662-672, 2013 | 30 | 2013 |
Revisiting proteasome inhibitors: molecular underpinnings of their development, mechanisms of resistance and strategies to overcome anti-cancer drug resistance C Leonardo-Sousa, AN Carvalho, RA Guedes, PMP Fernandes, ... Molecules 27 (7), 2201, 2022 | 24 | 2022 |
Inorganic Coordination Chemistry: Where We Stand in Cancer Treatment? P Pedrosa, A Carvalho, PV Baptista, AR Fernandes Basic concepts viewed from frontier in inorganic coordination chemistry, 37-65, 2018 | 23 | 2018 |
Evaluation of the in vitro and in vivo efficacy of ruthenium polypyridyl compounds against breast cancer OA Lenis-Rojas, C Roma-Rodrigues, AR Fernandes, A Carvalho, ... International journal of molecular sciences 22 (16), 8916, 2021 | 7 | 2021 |
Protein oxidative modifications in neurodegenerative diseases: from advances in detection and modelling to their use as disease biomarkers SI Anjo, Z He, Z Hussain, A Farooq, A McIntyre, CA Laughton, ... Antioxidants 13 (6), 681, 2024 | 4 | 2024 |
Cholesterol redistribution triggered by CYP46A1 gene therapy improves major hallmarks of Niemann-Pick type C disease but is not sufficient to halt neurodegeneration MJ Nunes, AN Carvalho, J Reis, D Costa, M Moutinho, J Mateus, ... Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1870 (3), 166993, 2024 | 2 | 2024 |